cellceutix is an emerging bio-pharmaceutical company
focusing in the areas of cancer
and inflammatory disease...
Press Release 11/7/2011

Cellceutix Files Investigational New Drug Application (IND) with FDA, Clinical Trials Planned at Dana-Farber/Harvard Cancer Center
 
 
SEC Filings
CLICK HERE to SEC FILINGS
 
 
Contact Us
Stay in the Know
Talk to Us
SEC Filings
Stock Information